solidagenone has been researched along with Leishmaniasis, Cutaneous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Arakawa, NS; Bortoleti, BTDS; Carloto, AC; Concato, VM; Conchon-Costa, I; Costa, IN; de Matos, RLN; Detoni, MB; Fattori, V; Gonçalves, MD; Miranda-Sapla, MM; Pavanelli, WR; Rodrigues, ACJ; Silva, TF; Tomiotto-Pellissier, F; Verri, WA; Wowk, PF | 1 |
1 other study(ies) available for solidagenone and Leishmaniasis, Cutaneous
Article | Year |
---|---|
Solidagenone in vivo leishmanicidal activity acting in tissue repair response, and immunomodulatory capacity in Leishmania amazonensis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Arginase; Furans; Leishmania; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Naphthalenes; NF-E2-Related Factor 2; NF-kappa B; Wound Healing | 2022 |